Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Clinical Study of Mitochondria-targeted System Therapy Combined With Radiofrequency Ablation for Early-stage Non-small Cell Lung Cancer

NCT03840408 is registered in ClinicalTrials.gov with Shanghai 10th People's Hospital as lead sponsor.

NCT NCT03840408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03840408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Clinical Study of Mitochondria-targeted System Therapy Combined With Radiofrequency Ablation for Early-stage Non-small Cell Lung Cancer
Lead sponsor
Shanghai 10th People's Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2019
Completion date
January 31, 2024
Enrollment
1,753 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer